Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura.

Autor:	González-Lois, C1, Ballestín, C1, Sotelo, M T1, López-Ríos, F1, García-Prats, M D1, Villena, V1
Zdroj:	Histopathology. Jun2001, Vol. 38 Issue 6, p528-534. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu